Related Experiment Videos
Carotid and coronary atherosclerosis. What are the connections?
1Department of Internal Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina.
Insights
Carotid atherosclerosis is linked to coronary atherosclerosis, mirroring the connection between cerebrovascular disease and coronary artery disease (CAD). Ultrasound imaging helps identify risk factors and test treatments for carotid atherosclerosis.
Area of Science:
- Cardiovascular medicine
- Vascular biology
- Diagnostic imaging
Background:
- A parallel association exists between carotid atherosclerosis and coronary atherosclerosis, similar to known links between cerebrovascular and coronary artery disease (CAD).
- B-mode ultrasonography is validated for quantitative imaging of extracranial carotid arteries.
Purpose of the Study:
- To identify risk factors for extracranial carotid atherosclerosis and its progression.
- To evaluate pharmacologic agents for retarding carotid atherosclerosis progression.
- To assess the role of extracranial carotid atherosclerosis as a marker for symptomatic CAD.
Main Methods:
- Utilizing B-mode ultrasonography for quantitative imaging of extracranial carotid arteries.
- Investigating associations between carotid atherosclerosis extent and symptomatic CAD.
- Analyzing CAD as a predictor of extracranial carotid atherosclerosis progression.
Main Results:
- The extent of atherosclerosis in extracranial carotid arteries serves as a risk factor or marker for symptomatic CAD.
- Coronary artery disease (CAD) is a significant predictor for the progression of extracranial carotid atherosclerosis.
Conclusions:
- Findings reinforce the interconnectedness of carotid and coronary atherosclerosis.
- Quantitative ultrasound imaging provides a valuable tool for studying carotid atherosclerosis.
- Identifying shared risk factors and progression predictors is crucial for cardiovascular health.
Abstract:
In recent years research has revealed an association between carotid atherosclerosis and coronary atherosclerosis that parallels the long-recognized association between clinically manifest cerebrovascular disease and clinically manifest coronary artery disease (CAD). Validation of B-mode ultrasonography as a method for quantitative imaging of the extracranial carotid arteries has made it possible to identify risk factors for extracranial carotid atherosclerosis and its progression and to test pharmacologic agents for their ability to retard that progression. Extent of atherosclerosis in the extracranial carotid arteries has been shown to be a risk factor or "marker" for symptomatic CAD. In addition, CAD has been identified as an important predictor of progression of extracranial carotid atherosclerosis.